Evidence map›Paper›PMID 42378278›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2026

Phosphatidylinositol diphosphate binding by ESCRT-III filaments.

Akram Alian, John McCullough, Frank R Moss, Nathaniel Talledge, Arshad Mohammed, Cecilia D Gerstner, Jacob A Dalluge, Elliott L Paine, Omar Davulcu, Chi-Lun Chang and 2 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Akram Alian *Department of Biochemistry, University of Utah Spencer Fox Eccles School of Medicine, Salt Lake City, UT 84112.
John McCullough *Department of Biochemistry, University of Utah Spencer Fox Eccles School of Medicine, Salt Lake City, UT 84112.
Frank R Moss *Discovery Science, Altos Labs, Redwood City, CA 94065.
Nathaniel TalledgeDiscovery Science, Altos Labs, Redwood City, CA 94065.
Arshad MohammedDiscovery Science, Altos Labs, Redwood City, CA 94065.
Cecilia D GerstnerDepartment of Biochemistry, University of Utah Spencer Fox Eccles School of Medicine, Salt Lake City, UT 84112.
Jacob A DallugeDepartment of Biochemistry, University of Utah Spencer Fox Eccles School of Medicine, Salt Lake City, UT 84112.
Elliott L PaineDepartment of Biochemistry, University of Utah Spencer Fox Eccles School of Medicine, Salt Lake City, UT 84112.
Omar DavulcuPacific Northwest Center for Cryoelectron Microscopy, Oregon Health & Science University, Portland, OR 97201.
Chi-Lun ChangDepartment of Cell and Molecular Biology, St. Jude Children's Research Hospital, Memphis, TN 38105.ORCID 0000-0003-0017-2243
Adam FrostDiscovery Science, Altos Labs, Redwood City, CA 94065.
Wesley I SundquistDepartment of Biochemistry, University of Utah Spencer Fox Eccles School of Medicine, Salt Lake City, UT 84112.ORCID 0000-0001-9988-6021

Funding

Pacific Northwest Center for Cryo-EM: Equipment SupplementR24GM154185 · NIGMS · OREGON HEALTH & SCIENCE UNIVERSITY · PI James E Evans, CLAUDIA SUSANA LOPEZ · 2024 to 2026
$21.5M
Biochemistry of HIV-1 BuddingR37AI051174 · NIAID · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI WESLEY I. SUNDQUIST · 2017 to 2026
$5.6M
ESCRT-III and MIT Protein Complexes in CytokinesisR01GM112080 · NIGMS · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI CHRISTOPHER P. HILL, WESLEY I. SUNDQUIST · 2014 to 2026
$4.1M
LINEAR ION-TRAP /FOURIER TRANSFORM MASS SPECTROMETER: PROTEOMICS: DIABETESS10RR020883 · NCRR · UNIVERSITY OF UTAH · PI NELSON, CHAD P · 2005 to 2005
$500k
Maldi/ToF/ToF Mass Spectrometer for the University of UtahS10RR025532 · NCRR · UNIVERSITY OF UTAH · PI NELSON, CHAD C · 2010 to 2010
$490k
HHS | NIH (NIH) NIH R37 AI051174HHS | NIH (NIH) R24GM154185HHS | NIH (NIH) S10 RR020883-01 and 1 S10 RR025532-01A1NCRR NIH HHS S10 RR020883NCRR NIH HHS S10 RR025532NIAID NIH HHS R37 AI051174NIGMS NIH HHS R01 GM112080NIGMS NIH HHS R24 GM154185
6 · The paper itself

Abstract

Different inositol phospholipids (PIPs) distribute to distinct subcellular organelles, creating an addressing system that dictates the sites of action of PIP-binding proteins, including components of the Endosomal Sorting Complexes Required for Transport (ESCRT). The ESCRT machinery is recruited to remodel many different cellular membranes through combinatorial binding interactions made by the early-acting ESCRT-I and ESCRT-II complexes with PIPs, ubiquitin modifications, and membrane-specific adaptors. Membrane remodeling, constriction, and fission are then mediated by membrane-associated filaments formed by subunits of the late-acting ESCRT-III complexes, together with their associated VPS4 AAA ATPases. Here, we describe two different classes of helical ESCRT-III filaments that can surround and tubulate membranes containing PIP

Indexed as

Endosomal Sorting Complexes Required for TransportPhosphatidylinositol 4,5-DiphosphateSaccharomyces cerevisiae ProteinsCell MembraneCryoelectron MicroscopyModels, MolecularProtein BindingSaccharomyces cerevisiaeEndosomal Sorting Complexes Required for TransportPhosphatidylinositol 4,5-DiphosphateSaccharomyces cerevisiae ProteinsEndosomal Sorting Complexes Required for Transport (ESCRT)ESCRT-III filamentsmembrane remodelingphosphatidylinositols

Identifiers

PMID42378278
PMCPMC13342873

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.